Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA

Completed

Conditions studied: Zika Virus Infection

In brief

The purpose of this study is to evaluate the performance of the ZIKV Detect™ 2.0 IgM Capture ELISA using archived confirmed ZIKV positive and confirmed ZIKV negative human serum samples.

Key facts

Study ID

NCT03776903

Run by

InBios International, Inc.

People needed

600

Starts

2018-04-01

Expected to finish

2018-09-30

Last updated by the study team

2018-12-17

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Human males and females of varying ages and geographical locations where Zika virus is endemic and not endemic.
• Retrospective (archived) and prospective human serum samples. Archived samples will fall under the category of "leftover" specimens as described by FDA guidance.

You may not qualify if…

• Samples that are not de-identified.

Where it is running

• InBios International — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.